Adjuvant chemotherapy for rectal cancer still controversial

The Lancet Oncology

Volumn 15, Issue 2, 2014, Pages 130-

  Beets, Geerard L ^a   Glimelius, Bengt L ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); COLON CANCER; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; LETTER; MICROMETASTASIS; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM CANCER; RECTUM SURGERY; RECURRENCE RISK; RISK REDUCTION;

EID: 84892990247     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70016-6     Document Type: Letter

References (9)

1. Engelen SM, Maas M, Lahaye MJ, et al. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer 2013, 49:2311-2320.
2. Wolpin BM, Mayer RJ Systemic treatment of colorectal cancer. Gastroenterology 2008, 134:1296-1310.
3. Glimelius B, Tiret E, Cervantes A, Arnold D, Group EGW Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013, 24(suppl 6):vi81-vi88.
4. van de Velde CJ, Boelens PG, Borras JM, et al. EURECCA colorectal: Multidisciplinary management: European consensus conference colon and rectum. Eur J Cancer 2014, 50:1. e1-e34.
5. Bosset J-F, Calais G, Mineur L, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 2014, for the EORTC Radiation Oncology Group, published online Jan 17. http://dx.doi.org/10.1016/S1470-2045(13)70599-0.
6. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
7. Cionini L, Sainato A, De Paoli A, et al. Final results of randomized trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer. Radiother Oncol 2010, 96(suppl 1):S113-S114.
8. Breugom AJ, van den Broek CBM, van Gijn W, et al. The value of adjuvant chemotherapy in rectal cancer patients after preoperative radiotherapy or chemoradiation followed by TME-surgery: the PROCTOR/SCRIPT study. Eur J Cancer 2013, 49(suppl 3):S1.
9. Glynne Jones R, Counsell M, Meadows H, Sebag-Montefiore D Chronicle: a phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine/oxaliplatin versus control. Ann Oncol 2013, 24(suppl 4):iv18.